Fortrea Holdings Inc. (FTRE) Stock

Fortrea Holdings Inc. (FTRE) is a Healthcare stock trading at $15.31 (as of 2026-06-18), with a market capitalization of $1.46B and a trailing P/E of -3.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Fortrea Holdings Inc. provides biopharmaceutical product and medical device development services worldwide through Clinical Services and Enabling Services. Its Clinical Services covers clinical pharmacology and development, while Enabling Services focuses on patient access and clinical trial technology for trial execution and drug supply, serving pharmaceutical, biotechnology, and medical device organizations.

Valuation — source: SEC EDGAR (first-party)
Price$15.31
Market Cap$1.46B
P/E Ratio-3.4
EV / EBITDA-8.9
Price / Book2.96
Price / Sales0.58
DCF Value (model)$3.72
DCF Upside vs Price-75.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.72B
Net Margin-36.2%
Return on Equity-85.0%
Debt / Equity2.00
Current Ratio0.95
Revenue Growth (YoY)1.0%
EPS Growth (YoY)194.6%
FCF Growth (YoY)-62.8%
Financial Health — source: SEC EDGAR
Altman Z-Score-0.38 (distress)
Valuation vs Sector & Industry
Stock P/E-3.4
Sector P/E (Healthcare)21.0
Industry P/E (Healthcare Services)23.0
vs Sector-116.3%
vs Industry-114.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($143.71M)
Institutional Holders Tracked10
Congressional Trades (recent)1
Company
SectorHealthcare
IndustryHealthcare Services
CEOAnshul Thakral
Employees15,000
CountryUS
IPO Date2023-06-20

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • GRAIL, Inc. (GRAL)
  • QuidelOrtho Corporation (QDEL)
  • Celldex Therapeutics, Inc. (CLDX)
  • BillionToOne, Inc. (BLLN)
  • Anbio Biotechnology Class A Ordinary Shares (NNNN)
  • Neogen Corporation (NEOG)
  • Castle Biosciences, Inc. (CSTL)
  • CareDx, Inc (CDNA)
FTRE earnings history · FTRE institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.